`Patent No. 9,187,405
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`ARGENTUM PHARMACEUTICALS LLC
`Petitioner,
` v.
`NOVARTIS AG,
`Patent Owner.
`______________________
`Case IPR2017-01550
`U.S. Patent No. 9,187,405
`______________________
`
`PATENT OWNER’S MANDATORY NOTICES
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`Case No. IPR2017-01550
`Patent No. 9,187,405
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner submits the following Mandatory
`
`Notices:
`
`1.
`
`Real Parties-In-Interest (37 C.F.R. § 42.8(b)(1))
`
`The real parties-in-interest are Novartis AG and Novartis Pharmaceuticals
`
`Corporation. Other Novartis AG subsidiaries may have an interest.
`
`2.
`
`Related Matters (37 C.F.R. § 42.8(b)(2))
`
`No other judicial and administrative matters would affect, or be affected by, a
`
`decision in this proceeding.
`
`3.
`
`Lead and Back-Up Counsel (37 C.F.R. § 42.8(b)(3))
`
`Patent Owner designates the following counsel as lead and back-up counsel,
`
`both with Gibson, Dunn & Crutcher LLP:
`
`Lead Counsel:
`Jane M. Love, Ph.D.
`USPTO Reg. No. 42,812
`200 Park Avenue, 47th Floor
`New York, NY 10166
`Phone: (212) 351-3922
`Fax: (212) 351-6322
`jlove@gibsondunn.com
`
`Back-up Counsel:
`Robert W. Trenchard
`(pro hac vice filed concurrently)
`200 Park Avenue, 47th Floor
`New York, NY 10166
`Phone: (212) 351-3942
`Fax: (212) 351-5242
`rtrenchard@gibsondunn.com
`
`A power of attorney to transact all business in the United States Patent &
`
`Trademark Office in connection with the above-referenced inter partes review from
`
`Patent Owner to Gibson, Dunn & Crutcher LLP is attached hereto.
`
`4.
`
`Service Information (37 C.F.R. § 42.8(b)(4))
`
`3
`
`
`
`Case No. IPR2017-00584
`Patent No. 9,187,504
`
`Service of any documents via hand-delivery may be made at the postal mailing
`
`addresses of lead and back-up counsel identified above with courtesy copies to the
`
`following
`
`
`addresses:
`
`
`
`jlove@gibsondunn.com;
`
`and
`
`rtrenchard@gibsondunn.com.
`
`Patent Owner consents to electronic service at these same email addresses.
`
`5.
`
`Fee Payment Authorization (37 C.F.R. § 42.103)
`
`In accordance with 37 C.F.R. § 42.103(a), Patent Owner authorizes the United
`
`States Patent and Trademark Office to charge any applicable fees associated with
`
`this proceeding to Deposit Account No. 50-1408, and to credit any overpayment to
`
`the same account.
`
`Date: June 29, 2017
`
`Respectfully submitted,
`
`By: /Jane M. Love, Ph.D./
`Jane M. Love, Ph.D.
`Reg. No. 42,812
`
`Gibson, Dunn & Crutcher LLP
`200 Park Avenue, 47th Floor
`New York, NY 10166
`
`Lead Counsel for Patent Owner
`
`
`
`
`
`Case No. IPR2017-01550
`Patent No. 9,187,405
`
`CERTIFICATE OF SERVICE
`I hereby certify that on June 29, 2017, a true and accurate copy of PATENT
`
`OWNER’S MANDATORY NOTICES including a Power of Attorney was served
`
`via electronic mail on the following counsel of record for Petitioner:
`
`Teresa Stanek Rea: TRea@Crowell.com
`Deborah H. Yellin: DYellin@Crowell.com
`Shannon M. Lentz: SLentz@Crowell.com
`
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Ave, NW
`Washington, DC 20004-2595
`Telephone: (202) 624-2500
`
`Tyler C. Liu: TLiu@agpharm.com
`
`Argentum Pharmaceuticals, LLC
`Telephone: (202) 749-8605
`
`
`
`Dated: June 29, 2017
`
`/Jane M. Love, Ph.D./
`Jane M. Love, Ph.D.
`Reg. No. 42,812
`Lead Counsel for Patent Owners
`
`
`
`5
`
`
`
`